<DOC>
	<DOC>NCT00049972</DOC>
	<brief_summary>A study to obtain safety and tolerability data</brief_summary>
	<brief_title>Major Depressive Disorder Study In Adults</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Patient must have primary diagnosis of Major Depressive Disorder (MDD). Discontinued a selective serotonin reuptake inhibitor (SSRI)or serotoninnorepinephrine reuptake inhibitor (SNRI) regimen due to intolerability. Minimum time frame between last dose of previous antidepressant and initiation of study drug is one week. Maximum time frame between last dose of prior antidepressant and initiation of study drug is 2 months. Patient has previously been treated with the study drug. Is experiencing an adverse event attributed to previous SSRI/SNRI use that has not been resolved at least one week prior to Baseline Visit. Has a history of seizure disorder. Has met criteria for substance abuse or dependence within 6 months prior to Baseline Visit. Currently using an antidepressant. Currently pregnant.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Major Depressive Disorder Open-label discontinued</keyword>
</DOC>